Yunfei Zhao
Research Subjects
Yunfei Zhao has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Ling Yang
Department of Pathology, Suining Central Hospital, Suining, 629000, China
2 shared publications- Bin Lei
Department of Urology, the First Affiliated Hospital of Jinan University, Guangzhou, China
1 shared publication Haijun Liu
Department of Ultrasound, Suining Central Hospital, Suining, Sichuan 629000, P.R. China
1 shared publication- Haili Zhu
Hubei Key Laboratory of Environmental Risks and Related Diseases Precision Control, School of Basic Medical Sciences, Hubei University of Science and Technology, Xianning, China
1 shared publication - Hong Shen
Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China
1 shared publication Hongyan Jiang
Department of Pathology, Suining Central Hospital, Suining, Sichuan 629000, P.R. China
1 shared publication
Latest Publications
- Open Access
- 1 July 2024
- Published by Elsevier in Asian Journal of Surgery
- Vol. 47 (12) , 5414-5415
A well-differentiated neuroendocrine tumor of the left kidney
- 1 July 2024
- Published by Elsevier in Asian Journal of Surgery
- Vol. 47 (12) , 5414-5415
Open AccessA well-differentiated neuroendocrine tumor of the left kidney
- Open Access
- 4 December 2023
- Published by Spandidos Publications in Oncology Letters
- Vol. 27 (1) , 1-6
A rare presentation of primary cardiac diffuse large B‑cell lymphoma: A case report
Primary cardiac lymphomas display a low frequency, sudden onset, swift progression of illness and elevated mortality rates. The current study presents a unique instance of primary cardiac diffuse large B‑cell lymphoma and examines its clinical manifestations, pathological characteristics and differential diagnosis. A 64‑year‑old male patient sought medical attention due to cardiac debility and exertional dyspnea persisting for >10 days. Chest enhanced computed tomography revealed a moderately enhancing irregular mass in the ventricular area, exhibiting limited demarcation from the pericardium and left atrium, accompanied by irregular thickening of the interventricular septum. The postoperative specimen showed the presence of yellow fish‑like tumor tissue. Immunohistochemical analysis revealed the presence of lymphocytes positive for CD20, BCL‑2, BCL‑6, c‑Myc‑binding protein, mutated melanoma‑associated antigen 1 and CD79a, along with a high Ki‑67 proliferation index of 80%. Conversely, CD10, CD30, CD3, pan cytokeratin, cyclin D1, desmin and vimentin marker results were found to be negative. Additionally, in situ hybridization demonstrated a lack of Epstein‑Barr virus‑encoded small RNA expression. The present case report emphasizes the significance of conducting a thorough analysis of the clinical manifestations of diffuse large B‑cell lymphoma to assist clinicians in establishing a diagnosis and determining an effective treatment approach, thereby enhancing the patient's prognosis.
- 4 December 2023
- Published by Spandidos Publications in Oncology Letters
- Vol. 27 (1) , 1-6
Open AccessA rare presentation of primary cardiac diffuse large B‑cell lymphoma: A case report
Primary cardiac lymphomas display a low frequency, sudden onset, swift progression of illness and elevated mortality rates. The current study presents a unique instance of primary cardiac diffuse large B‑cell lymphoma and examines its clinical manifestations, pathological characteristics and differential diagnosis. A 64‑year‑old male patient sought medical attention due to cardiac debility and exertional dyspnea persisting for >10 days. Chest enhanced computed tomography revealed a moderately enhancing irregular mass in the ventricular area, exhibiting limited demarcation from the pericardium and left atrium, accompanied by irregular thickening of the interventricular septum. The postoperative specimen showed the presence of yellow fish‑like tumor tissue. Immunohistochemical analysis revealed the presence of lymphocytes positive for CD20, BCL‑2, BCL‑6, c‑Myc‑binding protein, mutated melanoma‑associated antigen 1 and CD79a, along with a high Ki‑67 proliferation index of 80%. Conversely, CD10, CD30, CD3, pan cytokeratin, cyclin D1, desmin and vimentin marker results were found to be negative. Additionally, in situ hybridization demonstrated a lack of Epstein‑Barr virus‑encoded small RNA expression. The present case report emphasizes the significance of conducting a thorough analysis of the clinical manifestations of diffuse large B‑cell lymphoma to assist clinicians in establishing a diagnosis and determining an effective treatment approach, thereby enhancing the patient's prognosis.
- Open Access
- 24 March 2014
- Published by Springer Nature in Diagnostic Pathology
- Vol. 9 (1) , 69
Expression of Tiam1 predicts lymph node metastasis and poor survival of lung adenocarcinoma patients
To assess the value of Tiam1 in predicting lymph node metastasis and survival after curative resection in patients with lung adenocarcinoma.
- 24 March 2014
- Published by Springer Nature in Diagnostic Pathology
- Vol. 9 (1) , 69
Open AccessExpression of Tiam1 predicts lymph node metastasis and poor survival of lung adenocarcinoma patients
To assess the value of Tiam1 in predicting lymph node metastasis and survival after curative resection in patients with lung adenocarcinoma.